Drug intelligence / Profile preview

bovine isophane insulin

Development stage
Unknown
Lead developer
Novo Nordisk
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

Bovine isophane insulin, also known as NPH (Neutral Protamine Hagedorn) insulin of bovine origin, is an intermediate-acting form of animal-derived insulin used to control blood glucose in people with diabetes mellitus. It consists of purified bovine (beef) insulin complexed with protamine and zinc at neutral pH to form a suspension that delays absorption and prolongs its action. The onset of action typically occurs within 1–3 hours after subcutaneous injection, peaks at 6–8 hours, and lasts up to 24 hours. Bovine insulins were widely used before the advent of recombinant human insulins but are now less common due to higher immunogenicity compared to human or porcine insulins. Bovine isophane insulin lowers blood glucose by facilitating cellular uptake and utilization of glucose and inhibiting hepatic glucose production[5][6]. Its primary indication is for the management of type 1 and type 2 diabetes mellitus[3][6].

Brand names
Hypurin isophane
Other names
isophane insulin (bovine)NPH insulin (bovine)intermediate-acting bovine insulinNeutral Protamine Hagedorn (NPH) insulin (bovine)
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on bovine isophane insulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bovine isophane insulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call